Singapore markets close in 4 hours 48 minutes
  • Straits Times Index

    3,389.79
    +5.50 (+0.16%)
     
  • Nikkei

    27,732.31
    +222.85 (+0.81%)
     
  • Hang Seng

    21,157.38
    -503.09 (-2.32%)
     
  • FTSE 100

    7,901.80
    +81.64 (+1.04%)
     
  • BTC-USD

    22,920.34
    -427.53 (-1.83%)
     
  • CMC Crypto 200

    525.83
    -11.03 (-2.05%)
     
  • S&P 500

    4,136.48
    -43.28 (-1.04%)
     
  • Dow

    33,926.01
    -127.89 (-0.38%)
     
  • Nasdaq

    12,006.96
    -193.84 (-1.59%)
     
  • Gold

    1,889.00
    +12.40 (+0.66%)
     
  • Crude Oil

    73.50
    +0.11 (+0.15%)
     
  • 10-Yr Bond

    3.5320
    +0.1360 (+4.00%)
     
  • FTSE Bursa Malaysia

    1,490.47
    +0.67 (+0.04%)
     
  • Jakarta Composite Index

    6,866.45
    -45.28 (-0.66%)
     
  • PSE Index

    6,937.51
    -89.87 (-1.28%)
     

Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Let's take a look at what these Wall Street heavyweights have to say about Procter & Gamble (PG) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

P&G currently has an average brokerage recommendation (ABR) of 1.63, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 12 brokerage firms. An ABR of 1.63 approximates between Strong Buy and Buy.

Of the 12 recommendations that derive the current ABR, seven are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 58.3% and 16.7% of all recommendations.



Check price target & stock forecast for P&G here>>>

The ABR suggests buying P&G, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABR

In spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Is PG a Good Investment?

In terms of earnings estimate revisions for P&G, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $5.83.

Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for P&G. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for P&G.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Procter & Gamble Company The (PG) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research